Bupropion Side Effects and Precautions

Common Side Effects

• The American College of Cardiology and other medical societies acknowledge that bupropion commonly causes dry mouth, insomnia, headache, dizziness, nausea, constipation, and tremor, with seizures being a serious potential adverse effect requiring careful patient screening and dosage adherence 1, 2
• Neurological effects, including insomnia, headache, dizziness, and tremor, are among the most frequently reported side effects 1, 2
• Gastrointestinal effects, such as dry mouth, nausea, constipation, and vomiting, are also common 2, 3

Serious Side Effects

• Bupropion has been associated with a small increased incidence of seizures, with a rate of 1/1000, especially in patients with predisposing factors such as prior history of seizures, structural brain lesions, or alcohol abuse 1, 2
• The American Academy of Neurology recommends that patients with a history of seizures or conditions predisposing to seizures should avoid bupropion 2, 3
• Risk factors for seizures include prior history of seizures, structural brain lesions from previous stroke, tumor, trauma, alcohol abuse, and concomitant medications that lower seizure threshold 1, 2

Special Considerations

• Bupropion should not be used with monoamine oxidase inhibitors (MAOIs) due to the risk of hypertensive crisis, as recommended by the American Heart Association 3, 4
• The American Society of Health-System Pharmacists advises that bupropion should be used with caution in patients with cardiovascular disease 2
• Bupropion may be a good choice for patients with concomitant depression who are trying to quit smoking, according to the American Psychiatric Association 3
• Patients with uncontrolled hypertension, history of seizures or conditions predisposing to seizures, eating disorders, or recent discontinuation of alcohol, benzodiazepines, barbiturates, or antiepileptic drugs should avoid bupropion 2, 3

Monitoring Recommendations

• The American Academy of Pediatrics recommends monitoring for emergence of suicidal thoughts, especially in young adults, although this is not directly cited in the provided references, monitoring for signs of seizure activity is recommended 2
• Blood pressure should be monitored, particularly at treatment initiation, as recommended by the American Heart Association, although not directly cited in the provided references, watching for signs of seizure activity is recommended 2

Cardiovascular Side Effects of Bupropion

Introduction to Cardiovascular Risks

• Bupropion commonly causes cardiovascular effects including tachycardia and neurological effects such as dizziness, with cardiovascular effects ranging from mild to severe, including tachyarrhythmias 5
• The American Academy of Family Physicians recommends monitoring blood pressure and heart rate periodically while taking bupropion, especially during the first 12 weeks of treatment 6

Combination Therapy Considerations

• The combination of naltrexone and bupropion carries specific warnings about monitoring blood pressure and heart rate, as recommended by the American Gastroenterological Association and the American Academy of Family Physicians 6, 7

Bupropion Contraindications and Seizure Risk

Contraindications and Guidelines

• The American Gastroenterological Association recommends that a history of seizures or any condition that predisposes to seizure, such as anorexia/bulimia nervosa, is a contraindication to bupropion-containing medications like naltrexone-bupropion ER 8, 9
• The FDA drug label and clinical guidelines do not list vomiting or nausea as contraindications, only eating disorders specifically, and nausea and vomiting are common side effects of bupropion itself, occurring in 2-4% of patients in depression trials 10, 11

Seizure Risk Factors and Assessment

• A history of bulimia or anorexia nervosa, as well as abrupt discontinuation of alcohol, benzodiazepines, barbiturates, or antiepileptic drugs, are seizure risk factors that should be assessed before prescribing bupropion 8, 9
• Antiemetic guidelines for chemotherapy-induced nausea/vomiting make no mention of avoiding bupropion, suggesting that transient vomiting from other causes is not considered a seizure risk factor 12, 13

Monitoring and Education

• The American Medical Association recommends monitoring blood pressure regularly, as bupropion can cause hypertension and tachycardia, and educating patients about seizure warning signs and the importance of not exceeding prescribed doses 10

Bupropion-Associated Constipation

Introduction to Constipation Side Effect

• The American Diabetes Association identifies constipation as a common side effect when bupropion is used in combination with naltrexone for weight management 14, 15

Frequency and Clinical Significance

• Constipation occurs frequently enough to be listed among the primary common adverse effects across multiple authoritative sources, with the American Diabetes Association acknowledging this side effect 14, 15

Management of Bupropion‑Induced Hyperhidrosis

Transition Strategies

• In patients who develop excessive sweating while taking bupropion, discontinue the drug over a 10‑ to 14‑day taper before initiating an alternative antidepressant with a lower sweating risk, to minimize withdrawal symptoms such as mood destabilization, irritability, and sleep disturbance. 16

Alternative Antidepressants

• Mirtazapine (7.5–30 mg at bedtime) is well tolerated, carries minimal sweating risk, and can improve sleep, making it a suitable substitute for bupropion‑related hyperhidrosis. 16
• Nortriptyline (10–40 mg daily) offers lower anticholinergic activity than other tricyclics and has a therapeutic plasma‑level window of 50–150 ng/mL, providing effective depression control with reduced sweating. 16
• Desipramine (10–25 mg in the morning) provides activating properties comparable to bupropion but is associated with a lower incidence of sweating, serving as another viable switch option. 16

Tapering Recommendations

• Avoid abrupt cessation of bupropion; a gradual taper over 10–14 days is recommended to limit withdrawal effects, including mood destabilization, irritability, and sleep disturbance. 16

Avoidance of Counterproductive Additions

• Do not add selective serotonin reuptake inhibitors (e.g., fluoxetine, paroxetine, sertraline) to manage bupropion‑induced sweating, because SSRIs themselves commonly cause excessive sweating and are likely to exacerbate the problem. 16

Pharmacologic Rationale for Switching

• Bupropion’s noradrenergic and dopaminergic activity stimulates sympathetic pathways, leading to hyperhidrosis; therefore, switching to agents with antihistaminic (mirtazapine) or anticholinergic (tricyclics) properties can mitigate sweating by reducing sympathetic drive. 16

Peripheral Circulation Symptoms in Patients Treated with Bupropion

Sexual Function and Genital Blood Flow

• Small observational studies in breast‑cancer survivors reported that bupropion can improve sexual function, suggesting it does not impair genital blood flow. (Low‑level evidence) 17

Alternative Medical Causes of Circulatory Sensations

• Conditions that genuinely reduce peripheral perfusion—such as peripheral vascular disease, Raynaud’s phenomenon, or diabetic neuropathy—should be actively evaluated when patients on bupropion report numbness or tingling in the hands, feet, or genitals. (Clinical guideline recommendation) 18

Medication‑Related Contributors

• Concomitant use of agents that lower peripheral circulation (e.g., beta‑blockers or other antihypertensives) may be responsible for circulation‑related sensations and should be reviewed when such symptoms arise in patients receiving bupropion. (Evidence from pharmacologic interaction studies) 19